RECURRENT MULTIPLE MYELOMA
Clinical trials for RECURRENT MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test custom drug matching for tough blood cancers
Disease control OngoingThis pilot study is testing whether using genetic data and lab tests on a patient's cancer cells can help doctors choose more effective drugs for multiple myeloma or plasma cell leukemia that has returned or stopped responding to standard treatments. Researchers analyze bone marr…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test novel drug cocktail in fight against stubborn blood cancer
Disease control OngoingThis early-stage trial is testing a new three-drug combination for people with multiple myeloma that has come back or stopped responding to previous treatments. The main goal is to find the safest and most effective dose of a new experimental drug, CB-839, when given with two exi…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists test supercharged immune cells against stubborn blood cancer
Disease control OngoingThis early-stage study is testing a new combination treatment for multiple myeloma that has come back or stopped responding to other therapies. It combines a lab-modified version of a patient's own immune cells (called TiNK cells) with a drug called isatuximab, along with standar…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Elvira Umyarova • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug cocktail aims to tame Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a combination of four medications for people with multiple myeloma that has come back or stopped responding to prior treatments. The goal is to see if this drug combination can effectively control the cancer and extend the time patients live without their di…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for patients out of options: experimental combo targets stubborn blood cancer
Disease control OngoingThis study is testing a new combination of drugs for people with multiple myeloma, a blood cancer, that has come back and stopped responding to standard treatments. The main goals are to find the safest dose of the new drug selinexor when combined with other cancer drugs, and to …
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC